ReviewJournal of translational medicine2026
Healing dynamics and surgery in breast cancer: rethinking a timeless challenge in light of advancing therapies and technologies.
Review in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundDuring the last century, surgery became the primary approach for treating breast cancer. However, the introduction of new surgical techniques, increasingly less invasive and more conservative, did not always provide consistent benefits in inhibiting tumor progression. MAIN BODY: Inflammatory mechanisms involved in wound repair of surgical damage play a significant role in the progression of cancer. In this review we focused on the healing-induced inflammation processes that can favor residual tumor cells and on the latest current methods, which improve the rate of total tumor excision during the first operation or contribute to diminish host systemic inflammation boosting immune system activation in breast cancer patients.
conclusionsSurgery is still a crucial area of breast cancer research that attempts to understand how it might affect breast cancer progression and, ultimately, survival outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.